Dokument: Interleukin-31 targeting and other novel drugs in itch

Titel:Interleukin-31 targeting and other novel drugs in itch
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=72275
URN (NBN):urn:nbn:de:hbz:061-20260213-103700-6
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Oláh, Péter [Autor]
Homey, Bernhard [Autor]
Raap, Ulrike [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]746,3 KB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 13.02.2026 / geändert 13.02.2026
Beschreibung:Chronic pruritus is a debilitating symptom of several inflammatory skin conditions, presenting severe quality-of-life decreasing effects and major clinical challenges in terms of disease management. In the past decade, novel biological therapies have offered increasingly effective targeted interventions for the treatment of chronic pruritus, in which traditional approaches were often lacking or presented suboptimal safety profiles. However, recent advancements in the molecular characterization of sensory neuronal subsets helped to shed light on specific mechanisms of pruriception and thus have furthered our understanding of the peripheral nervous system and disease-relevant neuroimmune crosstalk. These developments have highlighted the targeting of interleukin-31, a major pruritus-associated cytokine, as a highly promising therapeutic target for chronic pruritus in inflammatory skin conditions. In this review, we therefore provide a focused overview of inflammatory conditions in which pruritus represents the major burden, the fundamental immune pathways, and sensory circuits involved, alongside the efficacies and safety profiles of novel therapies addressing chronic pruritus.
Rechtliche Vermerke:Originalveröffentlichung:
Oláh, P., Raap, U., & Homey, B. (2025). Interleukin-31 targeting and other novel drugs in itch. Annals of Allergy, Asthma, & Immunology, 136(2), 141–148. https://doi.org/10.1016/j.anai.2025.11.007
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:13.02.2026
Dateien geändert am:13.02.2026
english
Benutzer
Status: Gast
Aktionen